Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-14-020023
Filing Date
2014-04-01
Accepted
2014-04-01 17:14:27
Documents
14
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT v371700_10k.htm 10-K 1586468
2 EXHIBIT 23.1 v371700_ex23-1.htm EX-23.1 3127
3 EXHIBIT 23.2 v371700_ex23-2.htm EX-23.2 2815
4 EXHIBIT 31.1 v371700_ex31-1.htm EX-31.1 8669
5 EXHIBIT 32.1 v371700_ex32-1.htm EX-32.1 4547
6 GRAPHIC tpg7.jpg GRAPHIC 43260
7 GRAPHIC tpg9.jpg GRAPHIC 31617
8 GRAPHIC tpg12.jpg GRAPHIC 38144
  Complete submission text file 0001144204-14-020023.txt   11012722

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT nwbo-20131231.xml EX-101.INS 1844386
10 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20131231.xsd EX-101.SCH 117396
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20131231_cal.xml EX-101.CAL 60930
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20131231_def.xml EX-101.DEF 457422
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20131231_lab.xml EX-101.LAB 652479
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20131231_pre.xml EX-101.PRE 533129
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35737 | Film No.: 14735218
SIC: 2834 Pharmaceutical Preparations